Loading stock data…
Edwards Lifesciences Corporatio (EW)
$87.19-2.71 (-3.01%)
Market OpenUpdated 2:24 PM EDT
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Edwards Lifesciences Corporation in the Healthcare sector is trading at $87.19 with a market capitalization of $52.8B. Wall Street consensus targets $100.96 (26 analysts), implying a +15.8% move over the next 12 months. The stock is currently 9% below its 52-week high of $96.29, remaining 2.6% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +15.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 32) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.74B↑ | $1.65B↑ | $1.57B↑ | $1.55B↑ | $1.53B |
| Gross Profit | $1.35B↑ | $1.29B↑ | $1.23B↑ | $1.21B↑ | $1.19B |
| Operating Income | $519.50M↑ | $514.70M↑ | $370.30M↓ | $425.10M↓ | $430.90M |
| Net Income | $241.90M↓ | $380.70M↑ | $91.20M↓ | $291.10M↓ | $333.20M |
Peer Comparison
JNJUNHPFE
Fundamentals
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive re...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$52.80B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
54.52
Beta
Defensive asset. Lower volatility than the S&P 500.
0.85
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.46%
Volume
Today's trading volume
1.19M
Recent News
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
Intuitive Surgical is boosting R&D despite macro headwinds, targeting AI, robotics and new procedures to expand its market and drive long-term growth.
Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock
An unusually high volume of out-of-the-money (OTM) put options in Edwards Lifesciences (EW) shows investors are bullish on EW stock over the next three months. Moreover, EW is below analysts' price targets.
Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom
Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund delivered a 4.32% total return in Q2 2026, underperforming the 13.87% gain for the Russell 1000 Value Index and the 15.20% return for the S&P 500, while […]
Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.